|
CN1163504C
(zh)
|
1998-04-15 |
2004-08-25 |
阿温蒂斯药物公司 |
制备与树脂结合的环状肽的方法
|
|
US6316410B1
(en)
|
1999-09-22 |
2001-11-13 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
US20040023882A1
(en)
*
|
2002-05-16 |
2004-02-05 |
Peri Krishna G. |
PTH derivatives resistant to skin proteases
|
|
WO2004073587A2
(en)
*
|
2003-02-19 |
2004-09-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 1 (pthr1)
|
|
BRPI0412664A
(pt)
*
|
2003-07-15 |
2006-09-26 |
Ca Nat Research Council |
método para tratar uma condição caracterizada por hiperproliferação de células da pele em um indivìduo em risco ou portador dessa condição e utilização de uma quantidade terapeuticamente efetiva de um análogo cìclico de hormÈnio de paratireóide humano (hpth)
|
|
US7439226B2
(en)
*
|
2003-09-30 |
2008-10-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Serine protease inhibitors
|
|
US20060052306A1
(en)
*
|
2004-05-10 |
2006-03-09 |
Nastech Pharmaceutical Company Inc. |
GRAS composition for enhanced mucosal delivery of parathyroid hormone
|
|
US20060127320A1
(en)
*
|
2004-05-10 |
2006-06-15 |
Nastech Pharmaceutical Company Inc. |
Method of delivering parathyroid hormone to a human
|
|
MXPA06012980A
(es)
*
|
2004-05-10 |
2007-06-12 |
Nastech Pharm Co |
Composiciones y metodos para el suministro mucosal mejorado de la hormona paratiroidea.
|
|
US20060052305A1
(en)
*
|
2004-05-10 |
2006-03-09 |
Nastech Pharmaceutical Company Inc. |
Method of treating osteoporosis using intranasal parathyroid hormone
|
|
JP5086254B2
(ja)
|
2005-07-07 |
2012-11-28 |
フルクルム エスピー リミテッド |
Ｓｐ１ポリペプチド、変性ｓｐ１ポリペプチドおよびそれらの使用
|
|
US20070173447A1
(en)
*
|
2005-10-25 |
2007-07-26 |
Nastech Pharmaceutical Company Inc. |
Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
|
|
BRPI0618469A2
(pt)
*
|
2005-11-10 |
2011-08-30 |
Univ Michigan Tech |
hormÈnio paratiróide de urso preto e métodos de uso de hormÈnio paratiróide de urso preto
|
|
US20080051332A1
(en)
*
|
2005-11-18 |
2008-02-28 |
Nastech Pharmaceutical Company Inc. |
Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
|
|
CN101522709B
(zh)
*
|
2006-10-13 |
2013-03-20 |
伊莱利利公司 |
作为pth受体调节剂的聚乙二醇化的pth及其用途
|
|
EP2391377A2
(en)
|
2009-02-02 |
2011-12-07 |
Ramot at Tel-Aviv University Ltd. |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
|
WO2010113146A1
(en)
|
2009-04-01 |
2010-10-07 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
A method of regulating proliferation and differentiation of keratinocyes
|
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
|
JP5270799B2
(ja)
|
2009-07-29 |
2013-08-21 |
カイ・ファーマシューティカルズ・インコーポレイテッド |
副甲状腺ホルモンを低減する治療剤
|
|
EP2509996A1
(en)
|
2009-12-07 |
2012-10-17 |
Michigan Technological University |
Black bear parathyroid hormone and methods of using black bear parathyroid hormone
|
|
WO2011138785A2
(en)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of ccl1 in therapy
|
|
CN103002906B
(zh)
*
|
2010-05-13 |
2017-12-29 |
总医院有限公司 |
甲状旁腺激素类似物及其应用
|
|
EP2600885A2
(en)
|
2010-08-04 |
2013-06-12 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
|
WO2012173694A1
(en)
*
|
2011-06-17 |
2012-12-20 |
Fluidic, Inc. |
Ionic liquid containing sulfonate ions
|
|
DK2823040T3
(en)
|
2012-03-06 |
2018-11-19 |
Cellect Biotherapeutics Ltd |
DEVICES AND METHODS FOR SELECTING APOPTOSE SIGNALING RESISTANT CELLS AND APPLICATIONS THEREOF
|
|
WO2015040609A1
(en)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Erk-derived peptides and uses thereof
|
|
US20160340659A1
(en)
|
2014-01-30 |
2016-11-24 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
|
|
US20170174764A1
(en)
|
2014-03-27 |
2017-06-22 |
Yeda Research And Development Co. Ltd. |
T-cell receptor cdr3 peptides and antibodies
|
|
CN114949185A
(zh)
|
2015-02-09 |
2022-08-30 |
安特拉贝欧有限公司 |
骨质疏松症的治疗
|
|
EP3261582B1
(en)
|
2015-02-26 |
2021-01-06 |
Remodeless CV Ltd. |
Methods and compositions relating to leptin antagonists
|
|
CA2986705A1
(en)
|
2015-07-16 |
2017-01-19 |
Biokine Therapeutics Ltd. |
A cxcr4 inhibitor and a pdi antagonist for use in treating cancer
|
|
WO2017122209A2
(en)
|
2016-01-12 |
2017-07-20 |
Yeda Research And Development Co. Ltd. |
NF-kappaB INHIBITORS
|
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
|
EP3464322B1
(en)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Novel molecules for the treatment of inflammation
|
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
|
CN114887115A
(zh)
|
2016-12-01 |
2022-08-12 |
拉莫特特拉維夫大学有限公司 |
用于神经损伤的联合治疗
|
|
EA201992400A1
(ru)
|
2017-04-07 |
2020-04-16 |
Йисум Рисёч Девелопмент Кампани Оф Зэ Хибру Юниверсити Оф Джерузалем Лтд. |
Композиции для ухода за волосами
|
|
US20200172604A1
(en)
|
2017-05-23 |
2020-06-04 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
|
US11660270B2
(en)
|
2017-07-20 |
2023-05-30 |
Indiana University Research And Technology Corporation |
Nanoparticle compositions
|
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
|
US20200390800A1
(en)
|
2017-11-29 |
2020-12-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
|
SG11202013167UA
(en)
|
2018-07-11 |
2021-01-28 |
Kahr Medical Ltd |
SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
|
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
|
WO2021005599A1
(en)
|
2019-07-11 |
2021-01-14 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
|
CA3170374A1
(en)
|
2020-02-09 |
2021-08-12 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
|
IL296230A
(en)
|
2020-03-05 |
2022-11-01 |
Ariel Scient Innovations Ltd |
Anti-hemorrhaging compositions
|
|
EP4121441A1
(en)
|
2020-03-16 |
2023-01-25 |
Yeda Research and Development Co. Ltd |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein
|
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
|
EP4217370A2
(en)
|
2020-09-23 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods and compositions for treating coronaviral infections
|
|
EP4225903A1
(en)
|
2020-10-07 |
2023-08-16 |
Protalix Ltd. |
Long-acting dnase
|
|
EP4240423A1
(en)
|
2020-11-03 |
2023-09-13 |
Protalix Ltd. |
Modified uricase and uses thereof
|
|
CA3208982A1
(en)
|
2021-02-18 |
2022-08-25 |
Ravid STRAUSSMAN |
Method of generating vaccines
|
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
|
WO2023031934A1
(en)
|
2021-09-02 |
2023-03-09 |
Yeda Research And Development Co. Ltd. |
Agents that target the glycine arginine-rich domain of nucleolin and uses thereof
|
|
WO2024038462A1
(en)
|
2022-08-17 |
2024-02-22 |
Yeda Research And Development Co. Ltd. |
Novel bacteria-based delivery system for tace (adam17) selective biological inhibitor
|
|
WO2024241314A1
(en)
|
2023-05-22 |
2024-11-28 |
Neomanna Ltd |
Black soldier fly protein extracts
|